Correlation Between Neximmune and ABVC Biopharma
Can any of the company-specific risk be diversified away by investing in both Neximmune and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neximmune and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neximmune and ABVC Biopharma, you can compare the effects of market volatilities on Neximmune and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neximmune with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neximmune and ABVC Biopharma.
Diversification Opportunities for Neximmune and ABVC Biopharma
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Neximmune and ABVC is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Neximmune and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Neximmune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neximmune are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Neximmune i.e., Neximmune and ABVC Biopharma go up and down completely randomly.
Pair Corralation between Neximmune and ABVC Biopharma
If you would invest 243.00 in Neximmune on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Neximmune or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 4.76% |
Values | Daily Returns |
Neximmune vs. ABVC Biopharma
Performance |
Timeline |
Neximmune |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
ABVC Biopharma |
Neximmune and ABVC Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neximmune and ABVC Biopharma
The main advantage of trading using opposite Neximmune and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neximmune position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
ABVC Biopharma vs. Indaptus Therapeutics | ABVC Biopharma vs. Pasithea Therapeutics Corp | ABVC Biopharma vs. Forte Biosciences | ABVC Biopharma vs. Aileron Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
CEOs Directory Screen CEOs from public companies around the world | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |